Optimi Health Corp. is a Canadian-based pharmaceutical and life sciences company specializing in the research, cultivation, and manufacturing of controlled substances and functional mushrooms. Headquartered in Vancouver, the company operates a sophisticated, large-scale production facility in Princeton, British Columbia, which is Health Canada-licensed and GMP-compliant. Optimi Health is positioned as a vertically integrated provider in the emerging psychedelic therapy industry. The company focuses on producing high-quality, standardized psilocybin and MDMA for use in clinical trials and authorized therapeutic applications. Their facility is designed to meet the rigorous standards required for pharmaceutical supply chains, aiming to become a primary global supplier as regulatory frameworks for psychedelic medicine evolve. In addition to its controlled substances division, Optimi Health produces a range of functional mushroom supplements—including Lion's Mane, Reishi, and Cordyceps—targeted at the health and wellness consumer market. By combining advanced indoor growing technology with scientific research, the company seeks to validate the therapeutic benefits of fungi and provide safe, scalable solutions for mental health and physical performance. The company's strategy involves securing international export permits and establishing strategic partnerships with research institutions and healthcare providers worldwide.
How many years of EBITDA are required to pay off the company's net debt, according to the official accounting standard IFRS16. As a market consensus, a value of up to 3 years of leverage is accepted for most companies.
How much the company's debt represents in % in relation to its equity. As a market consensus, a value less than or equal to 1 is accepted, above that leverage can end up hurting the final result at some point.
The current ratio helps investors understand more about a company's ability to cover its short-term debt with its current assets and make apples-to-apples comparisons with its competitors and peers.
The quick ratio measures a company's capacity to pay its current liabilities without needing to sell its inventory or obtain additional financing and is considered a more conservative measure than the current ratio, which includes all current assets as coverage for current liabilities.
The interest coverage ratio is used to measure how well a firm can pay the interest due on outstanding debt and is is calculated by dividing a company's earnings before interest and taxes (EBIT) by its interest expense during a given period. Generally, a higher coverage ratio is better, although the ideal ratio may vary by industry.
...and much more!